Secondary analysis of the cluster-randomised VITAL-AF trial (16 937 patients aged ≥65): AI-ECG risk models predicted 2-year AF (AUROC up to 0.788); screening raised AF diagnoses only in the top risk decile (10.07 vs 7.76/100 person-years; NNS 43/year).
Secondary analysisn = 16,937
Vedage et al. Risk-Guided Atrial Fibrillation Screening With Artificial Intelligence-Enabled Electrocardiogram Models: A VITAL-AF Trial Analysis